Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma

被引：2
|
作者：
Liu, Yang
Bell, Taylor
Zhang, Hui
Sun, Yuting
Li, Carrie J.
Feng, Ningping
Huang, Shengjian
Guo, Hui
Wang, Jack
Ahmed, Makhdum
Zhang, Victoria
Lam, Laura T.
Nomie, Krystle
Zhang, Liang
Di Francesco, Maria E.
Marszalek, Joe
Wang, Michael
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.290.290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
290
引用
收藏
页数：3
相关论文
共 50 条
  • [41] CDK9 As a New Therapeutic Vulnerability for Ibrutinib Resistance Mantle Cell Lymphoma (MCL)
    Wang, Michelle
    Zhao, Xiaohong
    Jiang, Huijuan
    Yan, Joy Catherine
    Sotomayor, Eduardo
    Shain, Kenneth H.
    Shah, Bijal
    Tao, Jianguo
    BLOOD, 2020, 136
  • [42] Epigenetic targeting in mantle cell lymphoma
    Dunleavy, Kieron
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (06) : 805 - 806
  • [43] Targeting Hypersumoylation in Mantle Cell Lymphoma
    Hanel, Walter
    Tsyba, Liudmyla
    Huszar, Dennis
    Prouty, Alex
    Zhang, Xiaoli
    Helmig-Mason, JoBeth
    Mundy-Bosse, Bethany L.
    Youssef, Youssef
    Parekh, Samir
    Maddocks, Kami J.
    Baiocchi, Robert A.
    Alinari, Lapo
    BLOOD, 2019, 134
  • [44] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [45] Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment
    Zhang, Liang
    Newberry, Kate J.
    Wang, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (06) : 495 - 497
  • [46] IBRUTINIB PLUS PALBOCICLIB HAS EFFICACY IN MANTLE CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2019, 9 (03) : 318 - 318
  • [47] p110α Inhibition Overcomes Stromal Cell-Mediated Ibrutinib Resistance in Mantle Cell Lymphoma
    Guan, Jiyu
    Huang, Dan
    Yakimchuk, Konstantin
    Okret, Sam
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (05) : 1090 - 1100
  • [48] Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group
    Obr, Ales
    Klener, Pavel, Jr.
    Janikova, Andrea
    Mocikova, Heidi
    Belada, David
    Salek, David
    Jirkuvova, Andrea
    Papajik, Tomas
    Trneny, Marek
    BLOOD, 2021, 138
  • [49] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
  • [50] Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
    Tam, Constantine S.
    Anderson, Mary Ann
    Pott, Christiane
    Agarwal, Rishu
    Handunnetti, Sasanka
    Hicks, Rodney J.
    Burbury, Kate
    Turner, Gillian
    Di Iulio, Juliana
    Bressel, Mathias
    Westerman, David
    Lade, Stephen
    Dreyling, Martin
    Dawson, Sarah-Jane
    Dawson, Mark A.
    Seymour, John F.
    Roberts, Andrew W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1211 - 1223
12345